As a result, we observed a statistically significant positive Spearman’s correlation (p value < 0.05) between ESR1 and MYC, an estrogen-responsive gene whose overexpression may contribute to acquired resistance in ER+ breast cancers [135]. This evidence concerns the gene ESR1 and breast cancer.